| (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:1318046 | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of RPS6KA5 mRNA | CTD | PMID:22079256 |
| 17beta-estradiol | multiple interactions | ISO | RGD:1318046 | 6480464 | [Progesterone co-treated with Estradiol] results in decreased expression of RPS6KA5 mRNA | CTD | PMID:17404688 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1318047 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of RPS6KA5 mRNA | CTD | PMID:19933214 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of RPS6KA5 mRNA | CTD | PMID:19933214 |
| 4,4'-diaminodiphenylmethane | increases expression | ISO | RGD:1318047 | 6480464 | 4,4'-diaminodiphenylmethane results in increased expression of RPS6KA5 mRNA | CTD | PMID:18648102 |
| 4,4'-diaminodiphenylmethane | increases expression | ISO | | 6480464 | 4,4'-diaminodiphenylmethane results in increased expression of RPS6KA5 mRNA | CTD | PMID:18648102 |
| arsenite(3-) | increases activity | ISO | RGD:1318047 | 6480464 | arsenite results in increased activity of RPS6KA5 protein | CTD | PMID:11689710 |
| arsenite(3-) | increases activity | ISO | | 6480464 | arsenite results in increased activity of RPS6KA5 protein | CTD | PMID:11689710 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1318047 | 6480464 | Benzo(a)pyrene results in decreased expression of RPS6KA5 mRNA | CTD | PMID:22228805 |
| benzo[a]pyrene | decreases expression | ISO | | 6480464 | Benzo(a)pyrene results in decreased expression of RPS6KA5 mRNA | CTD | PMID:22228805 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:1318047 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in decreased expression of RPS6KA5 mRNA | CTD | PMID:21715664 |
| bis(2-chloroethyl) sulfide | decreases expression | ISO | | 6480464 | Mustard Gas results in decreased expression of RPS6KA5 mRNA | CTD | PMID:18955075 |
| bis(2-chloroethyl) sulfide | increases phosphorylation | ISO | RGD:1318047 | 6480464 | Mustard Gas results in increased phosphorylation of RPS6KA5 protein | CTD | PMID:18200059 |
| bis(2-chloroethyl) sulfide | decreases expression | ISO | RGD:1318047 | 6480464 | Mustard Gas results in decreased expression of RPS6KA5 mRNA | CTD | PMID:18955075 |
| bis(2-chloroethyl) sulfide | increases phosphorylation | ISO | | 6480464 | Mustard Gas results in increased phosphorylation of RPS6KA5 protein | CTD | PMID:18200059 |
| calcitriol | decreases expression | ISO | RGD:1318046 | 6480464 | Calcitriol results in decreased expression of RPS6KA5 mRNA | CTD | PMID:16002434 |
| cocaine | increases expression | EXP | | 6480464 | Cocaine results in increased expression of RPS6KA5 mRNA | CTD | PMID:17898221 |
| cocaine | multiple interactions | ISO | | 6480464 | Cocaine results in increased phosphorylation of and results in increased activity of RPS6KA5 protein; more ... | CTD | PMID:16339038 |
| cocaine | increases activity | ISO | | 6480464 | Cocaine results in increased activity of RPS6KA5 protein | CTD | PMID:16339038 |
| cocaine | affects response to substance | ISO | | 6480464 | RPS6KA5 affects the susceptibility to Cocaine | CTD | PMID:16339038 |
| cocaine | affects response to substance | ISO | RGD:1318047 | 6480464 | RPS6KA5 affects the susceptibility to Cocaine | CTD | PMID:16339038 |
| cocaine | increases activity | ISO | RGD:1318047 | 6480464 | Cocaine results in increased activity of RPS6KA5 protein | CTD | PMID:16339038 |
| cocaine | multiple interactions | ISO | RGD:1318047 | 6480464 | Cocaine results in increased phosphorylation of and results in increased activity of RPS6KA5 protein; more ... | CTD | PMID:16339038 |
| cyclosporin A | increases expression | ISO | RGD:1318046 | 6480464 | Cyclosporine results in increased expression of RPS6KA5 mRNA | CTD | PMID:20106945 |
| gallic acid | multiple interactions | ISO | RGD:1318046 | 6480464 | Gallic Acid inhibits the reaction [TNF protein results in increased phosphorylation of RPS6KA5 protein] | CTD | PMID:21420233 |
| hydralazine | multiple interactions | ISO | RGD:1318046 | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of RPS6KA5 mRNA | CTD | PMID:17183730 |
| hydrogen peroxide | increases activity | ISO | RGD:1318047 | 6480464 | Hydrogen Peroxide results in increased activity of RPS6KA5 protein | CTD | PMID:11689710 |
| hydrogen peroxide | increases activity | ISO | | 6480464 | Hydrogen Peroxide results in increased activity of RPS6KA5 protein | CTD | PMID:11689710 |
| phenylephrine | multiple interactions | EXP | | 6480464 | Phenylephrine results in increased phosphorylation of and results in increased activity of RPS6KA5 protein; more ... | CTD | PMID:15522277 |
| phenylephrine | multiple interactions | EXP | | 6480464 | RPS6KA5 protein promotes the reaction [Phenylephrine results in increased expression of JUN mRNA] | CTD | PMID:19002563 |
| pirinixic acid | multiple interactions | ISO | RGD:1318047 | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of RPS6KA5 mRNA | CTD | PMID:19710929 |
| pirinixic acid | multiple interactions | ISO | | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of RPS6KA5 mRNA | CTD | PMID:19710929 |
| progesterone | multiple interactions | ISO | RGD:1318046 | 6480464 | [Progesterone co-treated with Estradiol] results in decreased expression of RPS6KA5 mRNA | CTD | PMID:17404688 |
| quercetin | increases phosphorylation | ISO | RGD:1318046 | 6480464 | Quercetin results in increased phosphorylation of RPS6KA5 protein | CTD | PMID:18377872 |
| quercetin | multiple interactions | ISO | RGD:1318046 | 6480464 | PD 98059 inhibits the reaction [Quercetin results in increased phosphorylation of RPS6KA5 protein] | CTD | PMID:18377872 |
| Ro 31-8220 | decreases activity | EXP | | 6480464 | Ro 31-8220 results in decreased activity of RPS6KA5 protein | CTD | PMID:15522277 |
| succimer | multiple interactions | ISO | RGD:1318047 | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RPS6KA5 mRNA | CTD | PMID:21641980 |
| succimer | multiple interactions | ISO | | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RPS6KA5 mRNA | CTD | PMID:21641980 |
| valproic acid | multiple interactions | ISO | RGD:1318046 | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of RPS6KA5 mRNA | CTD | PMID:17183730 |